Leap Therapeutics, Inc.
LPTX
$0.2963
-$0.0137-4.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.92M | -69.64M | -68.02M | -64.82M | -60.34M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 5.00K | 9.00K | 12.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.29M | 6.38M | 6.43M | 4.94M | 5.39M |
| Change in Net Operating Assets | -447.00K | 3.99M | 1.29M | 4.71M | 4.89M |
| Cash from Operations | -60.08M | -59.26M | -60.30M | -55.17M | -50.06M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -196.00K | -77.00K | -- | -- | -- |
| Issuance of Common Stock | 120.00K | 40.12M | 40.13M | 40.03M | 40.03M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -66.00K | -2.95M | -2.95M | -2.95M | -2.88M |
| Cash from Financing | -142.00K | 37.09M | 37.18M | 37.08M | 37.15M |
| Foreign Exchange rate Adjustments | -129.00K | -39.00K | -279.00K | 167.00K | -26.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.35M | -22.21M | -23.39M | -17.92M | -12.94M |